188 related articles for article (PubMed ID: 1729390)
1. Rat brain adenosine deaminase after 2'-deoxycoformycin administration: biochemical properties and evidence for reduced enzyme levels detected by 2'-[3H]deoxycoformycin ligand binding.
Padua RA; Geiger JD; Delaney SM; Nagy JI
J Neurochem; 1992 Feb; 58(2):421-9. PubMed ID: 1729390
[TBL] [Abstract][Full Text] [Related]
2. 2'-Deoxycoformycin inhibition of adenosine deaminase in rat brain: in vivo and in vitro analysis of specificity, potency, and enzyme recovery.
Padua R; Geiger JD; Dambock S; Nagy JI
J Neurochem; 1990 Apr; 54(4):1169-78. PubMed ID: 2179470
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of 2'-deoxycoformycin, an inhibitor of adenosine deaminase, in the rat.
Geiger JD; Lewis JL; MacIntyre CJ; Nagy JI
Neuropharmacology; 1987 Sep; 26(9):1383-7. PubMed ID: 3499581
[TBL] [Abstract][Full Text] [Related]
4. Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.
Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R
Pharmacol Res; 2007 Aug; 56(2):124-31. PubMed ID: 17574432
[TBL] [Abstract][Full Text] [Related]
5. Influence of treatment with 3'-deoxyadenosine associated deoxycoformycin on hematological parameters and activity of adenosine deaminase in infected mice with Trypanosoma evansi.
Dalla Rosa L; Da Silva AS; Ruchel JB; Gressler LT; Oliveira CB; França RT; Lopes ST; Leal DB; Monteiro SG
Exp Parasitol; 2013 Oct; 135(2):357-62. PubMed ID: 23933282
[TBL] [Abstract][Full Text] [Related]
6. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
Barton RW
Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160
[TBL] [Abstract][Full Text] [Related]
7. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum.
Singhal D; Ho NF; Anderson BD
J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907
[TBL] [Abstract][Full Text] [Related]
8. Rapid determination of adenosine deaminase kinetics using fast-scan cyclic voltammetry.
Xu Y; Venton BJ
Phys Chem Chem Phys; 2010 Sep; 12(34):10027-32. PubMed ID: 20577678
[TBL] [Abstract][Full Text] [Related]
9. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
Singhal D; Morgan ME; Anderson BD
Pharm Res; 1997 Jun; 14(6):786-92. PubMed ID: 9210198
[TBL] [Abstract][Full Text] [Related]
10. Effect of adenosine kinase, adenosine deaminase and transport inhibitors on striatal dopamine and stereotypy after methamphetamine administration.
Gołembiowska K; Zylewska A
Neuropharmacology; 2000 Aug; 39(11):2124-32. PubMed ID: 10963755
[TBL] [Abstract][Full Text] [Related]
11. Specificity of 2'-deoxycoformycin inhibition of adenosine metabolism in intact human skin fibroblasts.
Holland MJ
Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):311-24. PubMed ID: 3486439
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of human adenosine deaminase to active forms that partially resist inhibition by pentostatin.
Ibrahim MM; Weber IT; Knudsen TB
Biochem Biophys Res Commun; 1995 Apr; 209(2):407-16. PubMed ID: 7733907
[TBL] [Abstract][Full Text] [Related]
13. Isolation of deoxycoformycin-resistant cells with increased levels of adenosine deaminase.
Hoffee PA; Hunt SW; Chiang J
Somatic Cell Genet; 1982 Jul; 8(4):465-77. PubMed ID: 6981855
[TBL] [Abstract][Full Text] [Related]
14. Prevention of insulin-dependent diabetes mellitus by 2'-deoxycoformycin in the BB Wistar rat.
Thliveris JA; Begleiter A; Kobrinsky NL; Verburg L; Dean HJ; Johnston JB
Biochem Pharmacol; 1993 Sep; 46(6):1071-5. PubMed ID: 8216350
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of recombinant interferon-alpha A and deoxycoformycin on adenosine deaminase activity in the Daudi B lymphoblastoid cell line.
Faltynek CR
Blood; 1988 Jan; 71(1):59-64. PubMed ID: 3257147
[TBL] [Abstract][Full Text] [Related]
16. Endogenous adenosine deaminase does not modulate synaptic transmission in rat hippocampal slices under normoxic or hypoxic conditions.
Zhu PJ; Krnjević K
Neuroscience; 1994 Nov; 63(2):489-97. PubMed ID: 7891860
[TBL] [Abstract][Full Text] [Related]
17. An adenosine deaminase inhibitor prevents puromycin aminonucleoside nephrotoxicity.
Nosaka K; Takahashi T; Nishi T; Imaki H; Suzuki T; Suzuki K; Kurokawa K; Endou H
Free Radic Biol Med; 1997; 22(4):597-605. PubMed ID: 9013123
[TBL] [Abstract][Full Text] [Related]
18. Sedative and electroencephalographic actions of erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA): relationship to inhibition of brain adenosine deaminase.
Mendelson WB; Kuruvilla A; Watlington T; Goehl K; Paul SM; Skolnick P
Psychopharmacology (Berl); 1983; 79(2-3):126-9. PubMed ID: 6405420
[TBL] [Abstract][Full Text] [Related]
19. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
[TBL] [Abstract][Full Text] [Related]
20. Optimization of the local inhibition of intestinal adenosine deaminase (ADA) by erythro-9-(2-hydroxy-3-nonyl)adenine: enhanced oral delivery of an ADA-activated prodrug for anti-HIV therapy.
Singhal D; Anderson BD
J Pharm Sci; 1998 May; 87(5):578-85. PubMed ID: 9572908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
